• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Demand for FMT likely to increase with rise in multiply recurrent C. difficile cases

byCaitlyn HuiandDeepti Shroff Karhade
July 6, 2017
in Emergency, Gastroenterology, Infectious Disease, Public Health, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Multiply recurrent Clostridium difficile infection (mrCDI) incidence has increased disproportionately to Clostridium difficile infection (CDI), independent of known risk factors for CDI.

2. There is a rising demand for mrCDI therapies in the future.

Evidence Rating Level: 2 (Good)

Study Rundown: CDI is a significant health concern. Not only is CDI a major health care-associated infection, but it also recurs frequently. In fact, 13% to 50% of patients will have at least 1 recurrence after an initial episode, known as mrCDI. These patients tend to require treatment by fecal microbiota transplantation (FMT)—a highly expensive therapy. The authors of this study aimed to determine whether the incidence of mrCDI is increasing in proportion to CDI and to identify risk factors for mrCDI. Generally, they observed that there is an excessive rise in mrCDI. This study has several limitations. First, only commercially insured American patients were included in the primary analysis. Additionally, administrative claims data was used to identify patients with CDI. Overall, the results of this study indicate that mrCDI has increased disproportionately to CDI; as such, FMT treatment demand may increase in the future.

Click to read the study, published in the Annals of Internal Medicine

Relevant Reading: The Reproductive Care of Women Living With Hepatitis C Infection

RELATED REPORTS

Multispecies probiotic reduces overall risk of diarrhea in antibiotic-treated children

Very-low-calorie diet leads to significant but reversible changes in gut microbiome

Wellness Check: Nutrition

In-Depth [retrospective cohort]: The authors of this study conducted a retrospective cohort study involving 38 911 718 commercially insured patients in the OptumInsight Clinformatics Database. Of this cohort, 45 341 patients developed CDI and 1669 developed mrCDI. The outcomes for this study included both age and sex-standardized incidence rates for CDI and mrCDI. It was observed that mrCDI increased at a disproportionate rate compared to CDI. For example, the annual incidence of CDI and mrCDI per 1000 person-years from 2001 to 2012 increased by 42.7% (from 0.4408 to 0.6289 cases) and 188.8% (From 0.0107 to 0.0309 cases), respectively. While the increase in mrCDI was independent of CDI risk factors, chronic kidney disease and diagnosis in nursing homes were associated with increased risk for mrCDI.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Clostridium difficile
Previous Post

Lower rates of hypoglycemia in patients treated with insulin degludec

Next Post

Combination treatment with calcineurin inhibitors and IL-2 enhances transplant survival [PreClinical]

RelatedReports

Probiotics improve colic, reduce GI disorders in infants
Gastroenterology

Multispecies probiotic reduces overall risk of diarrhea in antibiotic-treated children

July 13, 2022
Of Background Image
Gastroenterology

Very-low-calorie diet leads to significant but reversible changes in gut microbiome

July 27, 2021
Provision of medically-tailored meals linked with lower admissions and medical spending
Wellness

Wellness Check: Nutrition

July 22, 2021
Molecular testing for Clostridium difficile may not predict disease activity
Gastroenterology

Quick Take: Trends in diverting loop ileostomy vs. total abdominal colectomy as surgical management for Clostridium Difficile colitis

July 12, 2019
Next Post
Fatty liver disease may independently predict high-risk coronary disease

Combination treatment with calcineurin inhibitors and IL-2 enhances transplant survival [PreClinical]

Metformin treats Fragile X syndrome symptoms in mice [PreClinical]

Metformin treats Fragile X syndrome symptoms in mice [PreClinical]

Adalimumab use results in high clinical response rate in hidradenitis suppurativa

Homozygous complement component CD55 mutations cause novel gastrointestinal syndrome

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.